<Monte>
Case Summary - Scott E. Monte
[[Federal Register: January 23, 2008 (Volume 73, Number 15)]
[Notices]
[Page 3973]
From the Federal Register Online via GPO Access
[wais.access.gpo.gov]
[DOCID:fr23ja08-52]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Findings of Scientific Misconduct
ACTION: Notice.
SUMMARY: Notice is hereby given that the Office of Research Integrity
(ORI) and the Assistant Secretary for Health have taken final action in
the following case:
Scott E. Monte, Huntington Memorial Hospital, Pasadena, CA: Based on the findings
of an investigation conducted by Huntington Memorial Hospital (HMH) and
information obtained by the Office of Research Integrity (ORI) during
its oversight review, the U.S. Public Health Service (PHS) found that
Scott E. Monte, L.V.N., former Clinical Research Associate, HMH,
engaged in scientific misconduct by knowingly and intentionally
falsifying and fabricating clinical research records in HMH cancer
prevention and treatment protocols supported by National Cancer
Institute (NCI), National Institutes of Health (NIH), awards U10
CA69651, U10 CA12027, U10 CA32012, and U10 CA86004.
Specifically, Mr. Monte knowingly and intentionally:
(1) Entered falsified and fabricated laboratory data or physical
examination results on five (5) research protocol case report forms
(CRFs);
(2) Falsified a gynecological examination report in a physician's
progress note and entered the falsified document in the patient's
research chart; and
(3) Fabricated progress notes for four patients and a case report
form for one of these patients.
ORI has implemented the following administrative actions for a
period of three (3) years, beginning on January 7, 2008:
(1) Mr. Monte is debarred from any contracting or subcontracting
with any agency of the United States Government and from eligibility or
involvement in nonprocurement programs of the United States Government
pursuant to HHS' implementation of the OMB Guidelines to Agencies on
Governmentwide Debarment and Suspension at 2 CFR Part 376; and
(2) Mr. Monte is prohibited from serving in any advisory capacity
to PHS, including but not limited to service on any PHS advisory
committee, board, and/or peer review committee, or as a consultant.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative
Oversight
Office of Research Integrity
1101 Wootton Parkway, Suite 750
Rockville, MD 20852
(240) 453-8800
Chris B. Pascal,
Director
Office of Research Integrity.
|
Assurance
